{
    "clinical_study": {
        "@rank": "122668", 
        "arm_group": [
            {
                "arm_group_label": "Theralac probiotic", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Culturelle probiotic", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "We have designed this study to measure the effect of normal flora supplementation, using\n      available probiotics, on the incidence of Clostridium difficile-associated diarrhea\n\n      in a population of general inpatients who are receiving antibiotics."
        }, 
        "brief_title": "Evaluation of Probiotics and the Development of Clostridium Difficile Associated Diarrhea in Patients Receiving Antibiotics", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Development of Clostridium Difficile Associated Diarrhea", 
        "condition_browse": {
            "mesh_term": "Diarrhea"
        }, 
        "detailed_description": {
            "textblock": "General medical-surgical patients in a community hospital who are receiving antibiotics, and\n      who agree to participate, will be given one of two different probiotics, or placebo. Data\n      will be gathered during their hospitalization, and at one and three months following\n      hospital discharge. We expect to see a lower incidence of Clostridium difficile-associated\n      diarrhea in the probiotic groups when compared to the placebo group. We will also be looking\n      for differences between the effects of the two probiotics, which differ in strain types and\n      number of colony forming units per dose."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria: Any hospitalized patient who is age 19 or older and receiving\n        antibiotics.\n\n        -\n\n        Exclusion Criteria:\n\n          -  Feeding tube in place\n\n          -  Pregnancy\n\n          -  Milk or soy allergy\n\n          -  Sensitivity to lactose\n\n          -  Immunocompromised defined as:\n\n               1. Absolute neutrophil count (ANC) \u2264 500 cells/mm3\n\n               2. HIV\n\n               3. Cancer patient receiving chemotherapy or radiation therapy\n\n               4. Immune deficiency\n\n               5. Post organ transplant\n\n        Participants will be withdrawn from the study if they develop any of the exclusion\n        criteria during the hospitalization.\n\n        -"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "19 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 5, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01873872", 
            "org_study_id": "PROBIOTIC"
        }, 
        "intervention": [
            {
                "arm_group_label": "Theralac probiotic", 
                "intervention_name": "Theralac probiotic", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Culturelle probiotic", 
                "intervention_name": "Culturelle probiotic", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "placebo", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anti-Bacterial Agents", 
                "Antibiotics, Antitubercular"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "March 26, 2014", 
        "location": {
            "contact": {
                "email": "leanne.phillips@stvhs.com", 
                "last_name": "Leanne Phillips, Pharm.D", 
                "phone": "205-838-3109"
            }, 
            "contact_backup": {
                "email": "markmiddlebrooks@bellsouth.net", 
                "last_name": "Mark Middlebrooks, MD", 
                "phone": "205-380-0848"
            }, 
            "facility": {
                "address": {
                    "city": "Birmingham", 
                    "country": "United States", 
                    "state": "Alabama", 
                    "zip": "35235"
                }, 
                "name": "St. Vincent's East"
            }, 
            "investigator": [
                {
                    "last_name": "Mark Middlebrooks, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Leanne Phillips, Pharm.D", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Walter Ross, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Lee Wimberly, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Linda Adams, RPh", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Carrie Castleberry, RN", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "Evaluation of Probiotics and the Development of Clostridium Difficile Associated Diarrhea in Patients Receiving Antibiotics", 
        "overall_contact": {
            "email": "markmiddlebrooks@bellsouth.net", 
            "last_name": "Mark Middlebrooks, MD", 
            "phone": "205-380-0848"
        }, 
        "overall_official": [
            {
                "affiliation": "St. Vincent's East", 
                "last_name": "Leanne Phillips, Pharm.D", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "St. Vincent's East", 
                "last_name": "Walter Ross, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "St. Vincent's East", 
                "last_name": "Mark Middlebrooks, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "St. Vincent's East", 
                "last_name": "Lee Wimberly, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "St. Vincent's East", 
                "last_name": "Linda Adams, RPh", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "St. Vincent's East", 
                "last_name": "Carrie Castleberry, RN", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Development of Clostridium difficile associated diarrhea in patients receiving antibiotics", 
            "safety_issue": "No", 
            "time_frame": "Up to six months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01873872"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "St. Vincent's East, Birmingham, Alabama", 
        "sponsors": {
            "collaborator": {
                "agency": "Master Supplements, Inc", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "St. Vincent's East, Birmingham, Alabama", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}